Amgen has lost another round in its battle to fend off a biosimilar rival http://on.wsj.com/19C31Ps $AMGN $NVS
0 replies
26 retweets
21 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.